COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 163 filers reported holding COHERUS BIOSCIENCES INC in Q2 2023. The put-call ratio across all filers is 1.41 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $207,962 | -68.3% | 62,451 | -64.4% | 0.00% | -100.0% |
| Q3 2023 | $656,374 | -55.8% | 175,501 | -19.1% | 0.00% | -75.0% |
| Q1 2023 | $1,484,588 | -36.6% | 217,045 | -26.6% | 0.00% | -33.3% |
| Q4 2022 | $2,343,346 | -69.5% | 295,877 | -63.0% | 0.01% | -75.0% |
| Q3 2022 | $7,687,000 | -28.7% | 799,950 | -46.2% | 0.02% | -31.4% |
| Q2 2022 | $10,774,000 | +351.2% | 1,488,109 | +1162.6% | 0.04% | +118.8% |
| Q3 2019 | $2,388,000 | -71.2% | 117,864 | -68.8% | 0.02% | -69.8% |
| Q2 2019 | $8,287,000 | +72.4% | 377,199 | +7.0% | 0.05% | +65.6% |
| Q1 2019 | $4,806,000 | +483.3% | 352,370 | +286.8% | 0.03% | +433.3% |
| Q4 2018 | $824,000 | -10.5% | 91,101 | +63.2% | 0.01% | +50.0% |
| Q3 2018 | $921,000 | -79.5% | 55,831 | -82.6% | 0.00% | -80.0% |
| Q2 2018 | $4,485,000 | +2651.5% | 320,323 | +2071.5% | 0.02% | +1900.0% |
| Q1 2018 | $163,000 | – | 14,751 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 1,100,000 | $1,903,000 | 1.75% |
| AlphaCentric Advisors LLC | 1,000,000 | $1,730,000 | 1.27% |
| Tejara Capital Ltd | 1,030,386 | $1,782,568 | 0.65% |
| Rubric Capital Management LP | 10,400,000 | $17,992,000 | 0.47% |
| Birchview Capital, LP | 270,000 | $467,100 | 0.43% |
| TANG CAPITAL MANAGEMENT LLC | 1,050,000 | $1,816,500 | 0.18% |
| Bridge City Capital, LLC | 316,009 | $546,696 | 0.18% |
| Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $5,252,413 | 0.16% |
| Tyche Wealth Partners LLC | 215,902 | $373,510 | 0.09% |
| Pennant Investors, LP | 168,100 | $290,813 | 0.08% |